When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified

Background and Aims: Wireless capsule endoscopy (WCE) is used in Crohn′s disease (CD) to define disease extent. We aimed to define WCE detection rate of small bowel ulcerative lesions and completion rate in CD patients. Patients and Methods: A total of 102 consecutive CD patients, who successfully p...

Full description

Bibliographic Details
Main Authors: Panagiotis Tsibouris, Apostolopoulos Periklis, Kalantzis Chrissostomos, Zalonis Antonios, Mavrogianni Panagiota, Vlachou Erasmia, Alexandrakis Georgios
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2013;volume=19;issue=2;spage=63;epage=68;aulast=Tsibouris
id doaj-cd9d0cced93f484884f936ef69ce5e1f
record_format Article
spelling doaj-cd9d0cced93f484884f936ef69ce5e1f2020-11-24T22:05:14ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37671998-40492013-01-01192636810.4103/1319-3767.108468When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identifiedPanagiotis TsibourisApostolopoulos PeriklisKalantzis ChrissostomosZalonis AntoniosMavrogianni PanagiotaVlachou ErasmiaAlexandrakis GeorgiosBackground and Aims: Wireless capsule endoscopy (WCE) is used in Crohn′s disease (CD) to define disease extent. We aimed to define WCE detection rate of small bowel ulcerative lesions and completion rate in CD patients. Patients and Methods: A total of 102 consecutive CD patients, who successfully passed patency capsule, were matched to 102 controls. WCE was performed in both patients (in acute phase and CD clinical remission) and controls. Results: Eighty-six (84%) controls versus 62 (61%) patients in the acute phase ( P = 0.003) and 96 (94%) in remission ( P = 0.02) completed WCE study. Gastric passing time was 48 ± 66 min in controls, 66 ± 82 min in CD acute phase ( P = 0.03) and 30 ± 21 min in remission ( P = 0.07). Small bowel passing time was 276 ± 78 min in controls, 299 ± 78 min in the acute phase of CD ( P = 0.04) and 248 ± 89 min in remission ( P = 0.01). Mean capsule endoscopy Crohn′s disease activity index (CECDAI) score was 14 ± 6 in acute small bowel CD, 12 ± 7 in acute small-large bowel CD ( P = 0.08) and 2 ± 2 in both CD types while in remission ( P = 1.00). Small bowel ulcerative lesions in the acute phase were more frequently in distal small bowel. Aphthous ulcers were frequent a month after entering clinical remission and tend to disappear gradually later on. No ulcerative lesions were present in deep remission. Patency capsule is rather safe to exclude small bowel obstruction. Conclusions: (1) A high percentage of patients with active CD do not complete small bowel study with WCE. (2) Small bowel ulcerative lesions in clinical remission were less severe, although at least 6 months are needed in order for them to disappear.http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2013;volume=19;issue=2;spage=63;epage=68;aulast=TsibourisActive Crohn′s diseaseCrohn′s disease in remissionpatency capsulesmall bowelwire capsule endoscopy
collection DOAJ
language English
format Article
sources DOAJ
author Panagiotis Tsibouris
Apostolopoulos Periklis
Kalantzis Chrissostomos
Zalonis Antonios
Mavrogianni Panagiota
Vlachou Erasmia
Alexandrakis Georgios
spellingShingle Panagiotis Tsibouris
Apostolopoulos Periklis
Kalantzis Chrissostomos
Zalonis Antonios
Mavrogianni Panagiota
Vlachou Erasmia
Alexandrakis Georgios
When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified
The Saudi Journal of Gastroenterology
Active Crohn′s disease
Crohn′s disease in remission
patency capsule
small bowel
wire capsule endoscopy
author_facet Panagiotis Tsibouris
Apostolopoulos Periklis
Kalantzis Chrissostomos
Zalonis Antonios
Mavrogianni Panagiota
Vlachou Erasmia
Alexandrakis Georgios
author_sort Panagiotis Tsibouris
title When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified
title_short When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified
title_full When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified
title_fullStr When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified
title_full_unstemmed When Crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified
title_sort when crohn′s disease is in remission, more patients complete capsule endoscopy study but less lesions are identified
publisher Wolters Kluwer Medknow Publications
series The Saudi Journal of Gastroenterology
issn 1319-3767
1998-4049
publishDate 2013-01-01
description Background and Aims: Wireless capsule endoscopy (WCE) is used in Crohn′s disease (CD) to define disease extent. We aimed to define WCE detection rate of small bowel ulcerative lesions and completion rate in CD patients. Patients and Methods: A total of 102 consecutive CD patients, who successfully passed patency capsule, were matched to 102 controls. WCE was performed in both patients (in acute phase and CD clinical remission) and controls. Results: Eighty-six (84%) controls versus 62 (61%) patients in the acute phase ( P = 0.003) and 96 (94%) in remission ( P = 0.02) completed WCE study. Gastric passing time was 48 ± 66 min in controls, 66 ± 82 min in CD acute phase ( P = 0.03) and 30 ± 21 min in remission ( P = 0.07). Small bowel passing time was 276 ± 78 min in controls, 299 ± 78 min in the acute phase of CD ( P = 0.04) and 248 ± 89 min in remission ( P = 0.01). Mean capsule endoscopy Crohn′s disease activity index (CECDAI) score was 14 ± 6 in acute small bowel CD, 12 ± 7 in acute small-large bowel CD ( P = 0.08) and 2 ± 2 in both CD types while in remission ( P = 1.00). Small bowel ulcerative lesions in the acute phase were more frequently in distal small bowel. Aphthous ulcers were frequent a month after entering clinical remission and tend to disappear gradually later on. No ulcerative lesions were present in deep remission. Patency capsule is rather safe to exclude small bowel obstruction. Conclusions: (1) A high percentage of patients with active CD do not complete small bowel study with WCE. (2) Small bowel ulcerative lesions in clinical remission were less severe, although at least 6 months are needed in order for them to disappear.
topic Active Crohn′s disease
Crohn′s disease in remission
patency capsule
small bowel
wire capsule endoscopy
url http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2013;volume=19;issue=2;spage=63;epage=68;aulast=Tsibouris
work_keys_str_mv AT panagiotistsibouris whencrohnsdiseaseisinremissionmorepatientscompletecapsuleendoscopystudybutlesslesionsareidentified
AT apostolopoulosperiklis whencrohnsdiseaseisinremissionmorepatientscompletecapsuleendoscopystudybutlesslesionsareidentified
AT kalantzischrissostomos whencrohnsdiseaseisinremissionmorepatientscompletecapsuleendoscopystudybutlesslesionsareidentified
AT zalonisantonios whencrohnsdiseaseisinremissionmorepatientscompletecapsuleendoscopystudybutlesslesionsareidentified
AT mavrogiannipanagiota whencrohnsdiseaseisinremissionmorepatientscompletecapsuleendoscopystudybutlesslesionsareidentified
AT vlachouerasmia whencrohnsdiseaseisinremissionmorepatientscompletecapsuleendoscopystudybutlesslesionsareidentified
AT alexandrakisgeorgios whencrohnsdiseaseisinremissionmorepatientscompletecapsuleendoscopystudybutlesslesionsareidentified
_version_ 1725826672298557440